MAXIA PHARMACEUTICALS

Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs.

#SimilarOrganizations #Financial #More

MAXIA PHARMACEUTICALS

Industry:
Biotechnology Pharmaceutical

Address:
San Diego, California, United States

Country:
United States

Status:
Active

Contact:
(858)824-1988

Total Funding:
0


Similar Organizations

ds-biopharma-logo

DS Biopharma

DS Biopharma is a privately held drug discovery and development company.

merlion-pharma-logo

MerLion Pharma

MerLion Pharmaceuticals is a drug discovery and development company that researches and develops natural products.

not_available_image

NanoPacific Holdings

NanoPacific Holdings (NPH) is a privately held research and development company based in Los Angeles,

promiliad-biopharma-logo

Promiliad Biopharma

Promiliad Biopharma is an innovative drug discovery company that creates novel natural product-like small molecules.

Investors List

bay-city-capital_image

Bay City Capital

Bay City Capital investment in Venture Round - Maxia Pharmaceuticals

More informations about "Maxia Pharmaceuticals"

Maxia Pharmaceuticals - PitchBook

How much funding has Maxia Pharmaceuticals raised over time? Maxia Pharmaceuticals has raised $28M. Who are Maxia Pharmaceuticals’s investors? Bay City Capital, Ironbark Asset …See details»

Maxia Pharmaceuticals - Crunchbase

Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»

Maxia Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Maxia Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 4 literature, Drug:MX-6162, MX-895, MX-781, MX-7091, MX-6043.See details»

Maxia Pharmaceuticals - Products, Competitors, Financials, …

Headquarters Location. 10835 Altman Row Suite 250. San Diego, California, 92121, United States. 858-824-1988See details»

Maxia Pharmaceuticals Inc - Company Profile and News

Company profile page for Maxia Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»

Maxia Pharmaceutical - Ownership and Business Overview - Mergr

Feb 18, 2003 Maxia Pharmaceutical is a life science company. Life Science M&A Summary in 2003 Out of 60 sectors in the Mergr database, life science ranked 13 in number of deals in 2003 .See details»

Maxia Pharma - Bay City Capital

Maxia Pharma. Formed to exploit the non-dermatological applications of a patented library of compounds licensed from Galderma. The company focused on small molecule drugs that …See details»

Incyte acquires Maxia Pharmaceuticals - 2003-02-18 - Crunchbase

Feb 18, 2003 Maxia Pharmaceuticals Maxia Pharmaceuticals is a privately-held drug discovery and development company that specialized in small molecule drugs. Acquiring Organization: …See details»

Maxia Pharmaceuticals, Inc.:Company Profile & Technical Research ...

Maxia Pharmaceuticals Inc is a company that provides Drug discovery, Medicine, Molecule and more. Maxia Pharmaceuticals Inc is headquartered in United States California. Maxia …See details»

Maxia Pharmaceuticals, Inc. (Maxia Pharmaceuticals, Inc.) - 药 …

了解Maxia Pharmaceuticals, Inc. (Maxia Pharmaceuticals, Inc.)公司的药物管线,治疗领域,技术平台,以及它的4篇文献,药物:MX-7220,MX-895,MX-6162,MX-6043,MX-7091。See details»

MAXIA PHARMACEUTICALS, INC. - Maxia Pharmaceuticals, Inc.

Owner: Maxia Pharmaceuticals, Inc. Address: 10835 Altman Row Suite 250 San Diego DE 92121: Legal Entity Type: Corporation: Legal Entity State: DESee details»

Maxia Pharmaceuticals - CB Insights

Explore {Maxia Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Maxia …See details»

Incyte in $43M deal to buy Maxia Pharma - Pharmaceutical …

Mar 3, 2003 California, USA-based Incyte Genomics has completed the acquisition ofprivately-held drug discovery firm Maxia Pharmaceuticals in a deal worth around $43 million. Under the …See details»

Maxia Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...

See Maxia Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Maxia Pharmaceuticals's post-money valuation and revenue. Maxia …See details»

Maxia Pharmaceuticals, Inc.:Company Profile & Technical Research ...

Mar 26, 2023 Maxia Pharmaceuticals, Inc. is a company that provides Drug discovery, Medicine, Small molecule and more. Maxia Pharmaceuticals, Inc. is headquartered in United States …See details»

Maxia Pharmaceuticals, Inc. - US Patent and Trademark Search

Maxia pharmaceuticals inc uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office …See details»

Maxia Pharmaceuticals - Funding, Financials, Valuation & Investors

Nov 1, 1997 Maxia Pharmaceuticals has raised 1 round. This was a Venture - Series Unknown round raised on Nov 1, 1997 . Maxia Pharmaceuticals is funded by Bay City Capital .See details»

Incyte Buying Maxia For $28.3M; Plans Staff, Expense Reductions

Nov 13, 2002 Incyte Genomics Inc., known for its databases and research solutions, is acquiring Maxia Pharmaceuticals Inc. and its pipeline of early stage drugs for an amount that could …See details»

MX-6162 - Drug Targets, Indications, Patents - Synapse - Patsnap

MX-6162, Initially developed by Maxia Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Neoplasms,Skin and Musculoskeletal Diseases. ...See details»

MX-7220 - Drug Targets, Indications, Patents - Synapse - Patsnap

MX-7220, Initially developed by Maxia Pharmaceuticals, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Neoplasms,Respiratory Diseases ...See details»

linkstock.net © 2022. All rights reserved